Please select the category:
LATA-IBD TRIAL a Controlled Feasibility Study for the Introduction of Transanal Minimally Invasive IPAA-Surgery. Evaluation of Operative Results and Bowel Function After Introducing Transanal IPAA-surgery to Replace Conventional Laparoscopic IPAA-surgery.
Conditions: Ulcerative Colitis (Disorder); Familial Adenomatous Polyposis (FAP)
Sponsors: Sahlgrenska University Hospital
Completed
|
Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and Adults
Conditions: Atopic Dermatitis (AD)
Interventions: Drug: Ivarmacitinib Sulfate Tablets
Sponsors: Xiangya Hospital of Central South University
Not yet recruiting
|
Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates
Conditions: Preterm Less Than 32wks With IVH, WMI/PVL; Late Preterm or Term (37-42wks) With Neonatal Encephalopathy Treated With Hypothermia for HIE
Interventions: Other: Prospective Clinical and Neurodevelopmental Data Collection
Sponsors: Brigham and Women's Hospital; Boston Children's Hospital
Recruiting
|
A Multicenter Randomized Controlled Trial of Echocardiography-Guided Atrial Septal Defect Closure Performed in a Mobile Surgical Unit
Conditions: ASD - Atrial Septal Defect
Interventions: Other: Mobile Surgical Vehicle Echocardiography-guided ASD closure Group; Other: Conventional Operating Room Echocardiography-guided ASD closure Group
Sponsors: China National Center for Cardiovascular Diseases
Not yet recruiting
|
Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality
Conditions: Intraventricular Hemorrhage; Pulmonary Hemorrhage; Death; ELGAN (22-28SA); Bronchopulmonary Dysplasia (BPD); Shock; Extracellular Vesicles; Enterocolitis, Necrotizing
Interventions: Biological: Venous Cord blood sample; Biological: Arterial cord blood sample
Sponsors: University Hospital, Montpellier; INSERM U1046 Physiologie et médecine expérimentale du coeur et des muscles
Not yet recruiting
|
Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease
Conditions: Von Willebrand Disease (VWD), Type 2
Interventions: Drug: BT200; Drug: Placebo
Sponsors: Medical University of Vienna
Recruiting
|
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Conditions: Pre-eclampsia; Oocyte Donation; Pre-Eclampsia; Complicating Pregnancy; Pre-Eclampsia; Mild; Pre-Eclampsia, Severe; Pre-eclampsia or Eclampsia With Pre-existing Hypertension; ART; Neonatal Morbidity; Neonatal Mortality; Placental Abruption; Gestational Diabetes; Preterm Labor; Post-partum Hemorrhage (PPH); Intrauterine Growth Restriction (IUGR); Hypertensive Disorders of Pregnancy
Sponsors: Copenhagen University Hospital, Hvidovre; Ferring Pharmaceuticals; Gedeon Richter Ltd.
Recruiting
|
Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia
Conditions: Hemophilia
Interventions: Device: Control; Device: BFR Exercise (50% of the LOP) while Leg Press Exercise (4 Sets, All out)
Sponsors: University Hospital, Bonn
Enrolling by invitation
|
Link Between Abnormal Bleeding and Coagulation Disorders in Noonan Syndromes
Conditions: Noonan Syndrome
Interventions: Other: Reuse of routine clinical and biological data
Sponsors: University Hospital, Bordeaux
Not yet recruiting
|
A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia (HHT)
Interventions: Drug: TER-1754; Drug: Placebo; Drug: TER-1754
Sponsors: Terremoto Biosciences Inc.
Not yet recruiting
|